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ABSTRACT 
Title:  NICU sodium administration to extremely low birth weight infants:  
Relationships with recommendations and growth. 
Objectives.  To determine the amount of sodium being administered in the 
Neonatal Intensive Care Unit (NICU) from all sources including parenteral and 
enteral nutrition, medications, and intravenous solutions to extremely low birth 
weight (ELBW) infants -- those weighing less than or equal to 1000 grams.  It was 
hypothesized that there are variable amounts of sodium given, but those amounts 
are not adequate when compared to the recommendation of the American 
Academy of Pediatrics (AAP) (3-5 mEq/kg/d).   
Study design.  The study design was a retrospective chart review of surviving 
ELBW infants admitted to and discharged from the Women and Infants’ Hospital 
(WIH) NICU in Providence, Rhode Island from January 2009 through June 2011 
who were not enrolled in the NICU protein study.  Information on birth weight, 
gestational age, length of stay, growth velocity, average protein and calorie intake 
per kilogram, and average sodium intake per kilogram received from all sources 
was collected for eleven different time points.  
Results.  Seventy ELBW infants met the criteria for inclusion in this retrospective 
chart review.  Comparisons of the time points showed the highest amount of 
sodium per kilogram to be given at Day of Life 14 (4.52 mEq/kg) and only 
twenty-eight infants (40%) received the minimum amount recommended by the 
AAP (3-5 mEq/kg) all time points were compared.  When analyzed from week 2-
12 (week at which true growth occurs), only eight infants (11 %) of the infants 
  
 
received adequate amounts.  When growth velocity was compared with amount 
of sodium received (using 3 mEq/kg as cutoff), more growth was seen in the 
group given lower amounts of average sodium with the all-time points set 
(12.01±1.5 g/kg/day vs. 10.93±2.64 g/kg/day, p=0.034) and the same was true 
in the weeks 2-12 data set but no statistical significance was seen (p=0.84). 
Conclusions.  ELBW infants are receiving large amounts of inadvertent 
sodium from medications and intravenous solutions.  During weeks one and two 
of life, 88% and nearly 50% (respectively) of the sodium intake came from 
medications or intravenous solutions.  Even with the inadvertent amounts of 
sodium, most of the infants received suboptimal intakes of sodium compared to 
recommendations by the American Academy of Pediatrics (3-5 mEq/kg).  Growth 
velocity was compared with different levels of sodium (<3 mEq/kg vs ≥3 
mEq/kg).  More growth was seen in the group with the lower average sodium 
than those receiving the higher amount of sodium.  This could be explained by 
the morbidity level of these infants.  When growth rate of the infants who had no 
morbidities was compared to those infants with one or more morbidities, greater 
growth rates were seen in the group with no morbidities (12.80±1.3 g/kg/day vs. 
10.66±2.11, p=0.001). 
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CHAPTER 1 
 
INTRODUCTION 
 
Over the last ten years, changes in nutrition practices have improved 
growth in extremely low birth weight (ELBW) infants (≤1000 grams) (1).   The 
American Academy of Pediatrics recommends a postnatal growth rate that 
approximates that of a fetus of the same postconceptional age (≥15 g/kg/d) (2).   
Changes in nutrition practices include earlier parenteral nutrition, earlier enteral 
feeds, continuous feeds, protein fortification of human milk, and the development 
of feeding intolerance algorithms.  Hanson et al. compared growth pre- and post-
implementation of nutrition practice changes and found a decrease in 
extrauterine growth restriction (weight that is less than or equal to 10th 
percentile) from 57% (pre-implementation) to 28% (post-implementation) (3).  
Thiele et al. showed that 73% of these infants grew at or above fetal rates and 
had less extrauterine growth restriction (EUGR) compared to those 10 years 
prior (1). 
While attention has focused on increasing protein and calorie amounts to 
avoid growth failure (1,4,5,6), sodium and its requirements for optimal growth 
has not been thoroughly investigated even though hyponatremia (defined as a 
serum sodium concentration less than 135 mg/dL) is very common in the NICU 
and has been implicated as a reason for EUGR (3,7).  Sodium is needed for 
maintenance of extracellular fluid volume, bone mineralization, protein 
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synthesis, and the transport of glucose across cell membranes (8).  As a growth 
factor, sodium is important because it stimulates protein synthesis and increases 
cell mass and, as a result, inadequate sodium intake could lead to growth failure 
(8), and chronic sodium depletion has been found in many conditions related to 
failure to thrive (9).  Modi suggests that if energy intake is adequate, poor growth 
may be associated with sodium depletion even if serum sodium concentrations 
are within normal limits (7). 
 Experimental evidence in both humans and animals suggests that sodium 
depletion may in itself be responsible for poor growth (10).  The mechanism 
whereby sodium promotes growth is not completely understood, but it is 
hypothesized that the sodium/hydrogen antiporter system is a likely possibility 
(9).  The plasma membrane sodium-hydrogen exchanger plays a physiological 
role in the regulation of intracellular pH and the control of cell growth and 
proliferation and most likely does not function optimally with sodium deficiency 
(11). 
Wassner and Gallagher investigated sodium deficiency with subsequent 
supplementation of sodium chloride in young rats and found improved growth in 
the rats that were given sodium supplementation (12,13).   Vanpee et al. and Al-
Dahhan et al. conducted studies on preterm infants, giving extra sodium to 
infants between day of life four through fourteen and did see improved growth in 
those that received sodium supplementation, even after the sodium had been 
discontinued (14,15). 
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 Even when an infant is receiving adequate energy but continues with poor 
growth, chronic sodium depletion may be to blame.  There have been 
documented sodium deficiencies due to ileostomies, cystic fibrosis and various 
congenital deformities.   Wassner and Kulin gave sodium supplementation to one 
boy status post colon resection that was experiencing growth failure and saw a 
positive relationship between sodium intake and linear growth (10).  Bower et al. 
provided sodium supplementation to eleven infants who experienced metabolic 
abnormalities caused by ileostomy fluid losses and found a direct relationship 
between ileostomy output and the sodium intake required for growth (0.13 
mEq/kg/d of sodium for every ml/kg/d of ileostomy input) (16).  Sacher et al. 
saw similar findings in the retrospective follow up of 30 neonates with 
ileostomies (17).   In infants with cystic fibrosis, Coates et al. found that none of 
the ten infants in his study required more calories than their estimated needs 
when their diet was sodium supplemented. 
Recommendations by the AAP (1985) for sodium are based on Zeigler et 
al.’s factorial method as there are limited studies regarding the optimal amount of 
sodium needed for premature infants to promote growth.  The factorial method 
provides guidelines for all macronutrients and micronutrients and is based on 
daily tissue increment, dermal loss, urine loss, intestinal absorption to determine 
amounts required.  For the 800-1200 g infant (26-28 weeks’ gestation), 3.5 
mEq/kg of sodium is recommended (2).  Current recommendations have not 
altered from Ziegler’s original work and are presented as a range of sodium 
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intake (3-5 mEq/kg/d) for infants less than 1000 g from either enteral or 
parenteral nutrition (18). 
The present study quantified total sodium intakes of 70 ELBW infants 
admitted to the Neonatal Intensive Care Unit (NICU) at Women and Infants’ 
Hospital from January 1, 2009 through June 30, 2011 and compared values to 
recommended sodium intakes.  
Descriptive analyses and correlations were conducted on variables 
including growth velocity, gender, birth weight, total number of morbidities, 
nadir serum sodium value, zenith serum sodium value, average calories, average 
protein and average sodium (mean and standard deviation).  Multiple linear 
regressions were done based on correlations with growth velocity as the 
dependent variable.  
RESEARCH QUESTIONS 
Primary:  What are the average amounts of sodium being administered to 
extremely low birth weight infants in the Neonatal Intensive Care Unit at Women 
and Infants’ Hospital, Providence, Rhode Island? 
Secondary: 1) Are adequate amounts of sodium being given based on the 
recommendations of the American Academy of Pediatrics?   2)  Is there a 
correlation between average sodium intakes and growth velocity? 
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CHAPTER 2 
 
REVIEW OF LITERATURE 
Nutrition practices have improved growth rates over the last ten years in 
premature infants (1,4,5,6).  Despite these improvements, postnatal growth 
restriction of extremely low birth weight (ELBW) infants is quite common (4).  In 
a network cohort study, Ehrankranz found that the majority of ELBW infants 
were discharged at weights less than the 10th percentile of expected intrauterine 
growth and at 18-22 months’ corrected age, 50% remained below the 10th 
percentile (5).  There was also an association between poor weight and 
neurodevelopment impairment found in this study. 
Hanson, et al. compared growth pre- and post-implementation of a 
nutrition practice change (3).  These changes included earlier parenteral 
nutrition, earlier enteral feeds, continuous feeds, protein fortification of human 
milk, and the development of a feeding intolerance algorithm.  With the new 
guidelines, they found a decrease in extrauterine growth restriction (weight less 
than or equal to 10th percentile) from 57% (pre-implementation) to 28% (post-
implementation) and there was no difference between the groups with regard to 
NEC, IVH, or death rates (3). 
In a retrospective study of 88 ELBW infants with bronchopulmonary 
dysplasia (BPD), Thiele et al. showed that 73% of these infants grew at or above 
fetal rates and had less extrauterine growth restriction (EUGR) compared to 
those 10 years prior (1).  New strategies included early parenteral amino acid 
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administration closer to 3 g/kg/day, earlier initiation of enteral feedings, and 
fortification of human milk (19).   
EUGR refers to the concept that preterm infants develop a severe 
nutritional deficit during the first weeks after birth (20).  It has been shown to 
correlate negatively with neurodevelopmental milestones at 18 and 24 months’ 
corrected age (3,5,21).  Because of this concern, a primary goal in the NICU is 
maintaining adequate growth (≥15 g/kg/day) (20).  Complicating this goal are 
common morbidities of premature infants including patent ductus arteriosus 
(PDA), which is a delay in closure of ductus between aorta and pulmonary artery; 
bronchopulmonary dysplasia (BPD) or chronic lung disease of prematurity 
(CLD), which is a chronic pulmonary condition; necrotizing enterocolitis (NEC) 
which is characterized by abdominal distension, bilious aspirates and/or bloody 
stools; and intraventricular hemorrhage (IVH) which is an intracranial bleed 
ranging from mild to severe (22,23).  
The AAP recommends a postnatal growth rate that approximates that of a 
fetus of the same postconceptional age (≥15 g/kg/d) (2).  Premature infants with 
morbidities tend to grow more slowly than those without morbidities (4).  This is 
because sick infants’ feeds are interrupted more often, yet they have increased 
metabolic needs (20).  Premature infants with inadequate sodium intake and 
inadequate sodium retention also tend to grow more slowly than those with 
adequate sodium intake and retention (22). 
More attention has been given to increasing and optimizing 
macronutrients (protein and calories) (1,4,5,6), and sodium is not typically 
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examined in most large scale studies of growth in premature infants.  When an 
infant is meeting their energy needs but continues with poor growth, chronic 
sodium depletion may be to blame even with normal or low normal serum 
sodium concentration (22).  Chronic sodium deficiency has been associated with 
poor skeletal and tissue growth (22). 
Renal function 
 Kidneys in newborn infants have a limited capacity to excrete urine and 
conserve sodium (7,22).  This function occurs in the nephron which is the basic 
structural and functional unit of the kidney.  Development or growth of the 
kidney (nephrogenesis) continues until 36 weeks gestation (24).  Because of this, 
preterm infants are likely to have a reduced number of nephrons and therefore a 
decreased glomerular filtration rate (25).  After extracellular volume contraction 
occurs, the preterm infant is vulnerable to sodium depletion secondary to 
immature sodium reabsorption (25). 
Diuresis 
 Preterm infants less than 26 weeks’ gestation are approximately 80-90% 
water (7).  After birth, there is a sudden efflux of fluid from the intracellular fluid 
(ICF) compartment to the extracellular fluid compartment (ECF) (22,26).  The 
ECF consists mainly of water and sodium and with this increase in the ECF, the 
neonatal kidneys are flooded, resulting in salt and water diuresis by two to three 
days which amounts to weight loss of between 10-15% of birth weight during the 
first 5 days of life (26), and this percentage could even be as high as 20% (25).  
There is an inverse relationship between birth weight and weight loss percentage 
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during diuresis (26).  Failure to lose this fluid could result in overhydration and 
possibly lead to PDA and CLD (23). 
Adverse effects 
Adverse effects of excess sodium administration can be seen in the first 
few days of life and can increase the risk of hypernatremia (serum sodium >150 
mg/dL) especially if fluids are limited.   In a retrospective study of infants less 
than 27 weeks’ gestation, nearly 70% of hypernatremic infants developed CLD, 
PDA and IVH (23).  After diuresis, though, ELBW infants are at risk for chronic 
sodium depletion, and an intake of at least 4 mEq/kg/day is required (7). 
 Sodium is an important nutrient for preterm infants and is needed for 
maintenance of extracellular fluid volume, bone mineralization, protein 
synthesis, and the transport of glucose across cell membranes (8).  As a growth 
factor, sodium is important because it stimulates protein synthesis and increases 
cell mass (9).  As a result, inadequate sodium intake could lead to growth failure 
(8).  Chronic sodium depletion may be found in many conditions related to failure 
to thrive (9). 
Hyponatremia (defined as a serum sodium concentration less than 135 
mg/dL) is not always seen as the primary reason for growth restriction, but it is 
very common in the NICU and has been implicated as a reason for EUGR (3,7).  
Modi suggests that if energy intake is adequate, poor growth may be associated 
with sodium depletion even if serum sodium concentrations are within normal 
limits (7).  Experimental evidence in both humans and animals suggests that 
sodium depletion may in itself be responsible for poor growth (10). 
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Sodium requirements 
Sodium requirements vary on day of life.  Because of the prediuretic status 
of the baby, on day of life 0, a negative sodium balance is desired and only 0-1 
mEq/kg/day of sodium is recommended (7).   For the transition period 
(extracellular water contraction and weight loss) on days 1-5 of life, 2-5 
mEq/kg/day of sodium are recommended (30).  According to the AAP (18), 
current recommendations for the growing low birth weight infant are 3-5 mEq of 
sodium, which was first calculated by the reference fetus of Ziegler et al (6), 
although up to 7 mEq may be needed for babies experiencing late hyponatremia 
(27).  Goals may be underestimated because net gastrointestinal absorption of 
enteral feeds is approximately 70% (26).  Further complicating this goal is that 
very preterm infants have lower intestinal absorption of sodium or higher 
urinary losses than estimated (28). 
Some institutions give 4-6 mEq/kg/day of sodium on the second or third 
day of life (DOL) regardless of clinical status (29).  Hartnoll et al. and Al-Dahhan 
et al. recommended delaying sodium supplementation until DOL 4-5 or until 6% 
weight loss occurs to allow for fluid contraction (28,30).  Bhatia recommends no 
additional sodium until serum sodium is <130 mg/dL, then starting with 2-3 
mEq/kg/day (31). 
Animal Studies 
Wassner studied the effect of supplementing sodium-deficient young rats.  
Both the experimental and control groups received similar diets and distilled 
water for 2-3 weeks but the experimental group received 37 mEq of sodium 
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chloride.  The control group gained just 45% and 70% of weight and length, 
respectively, compared to the experimental group suggesting growth failure with 
sodium deficiency (12). 
Gallagher et al. also studied diet-induced sodium deficiency and measured 
the lung growth of young rats after undergoing left pneumonectomy (13).  As 
above, experimental and control groups were fed similar diets and distilled 
water, but the control group received 37 mEq of sodium chloride.  After the 7 
days, somatic growth was measured as well as lung mass, and it was shown that 
the sodium-deficient rats grew more slowly than the rats in the experimental 
group (13). 
Infant Studies 
As mentioned earlier, there is concern that early sodium supplementation 
could delay diuresis and therefore further increase expansion of extracellular 
compartment which, in turn, could affect the lungs and heart.   Early sodium 
administration could be possibly harmful and should be avoided until diuresis 
occurs (7).  Hartnoll et al. (2000) studied oxygen dependency and timing of 
sodium supplementation.  Twenty-four preterm infants of 25-30 weeks’ 
gestational age (weight range 745-1560 g) received sodium supplementation 
(sodium chloride) before six percent of birth weight was lost (experimental 
group), and delayed sodium supplementation in twenty-two infants (weight 
range 420-1570 g) until 6% body weight was lost (control group) (30).  The 
delayed sodium group had a large maximum weight loss than the early group 
(16.1% vs. 11.4%, p=0.02) but they saw no significant differences in time to 
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regain birth weight, weight at 36 weeks, nor six months of postmenstrual age.  
There was also a significant difference in oxygen requirement at seven days with 
35% of delayed group on room air compared with only 9% of early group on 
room air.  They concluded that delaying sodium supplementation until 6% of 
birth weight is lost is beneficial for lungs and did not compromise growth (30). 
Elstgeest et al. retrospectively compared two cohorts of infants <28 weeks 
who received either early TPN administration or late TPN administration (29).  
Due to a change in clinical practices, TPN was either started on day of life 0 or 1 
at 60-80 ml/kg (early TPN) or day of life three at 80-120 ml/kg (late TPN).  The 
early TPN group also received electrolytes within the first day of life.  They saw 
no statistically significant differences in sodium levels (141.8±3.8 vs. 141.0±3.7 
mEq/L), although loss of body weight was decreased in the early TPN group (-
6.0%±7.7 vs. -0.8%±8.0%).   They also found a higher weight gain in the early 
TPN group at day of life 14 and 21, but attributed this to increased protein 
administration, not sodium. 
Vanpee et al. (1995) studied twenty premature infants (gestational age 
29-34 weeks) at the Karolinska Hospital in Sweden.  Ten of the infants were 
randomly chosen to receive an additional 4 mEq of sodium chloride per kilogram 
from day of life 4 to day 14 of life, which amounted to total sodium amounts of 
5.0±0.9 mEq Na/kg (14).  The non-supplemented group received 1.7±0.6 
mEq/kg/day of NaCl.  Both groups were studied at one and two weeks of age.  No 
significant differences between the two groups were seen in gestational age, birth 
weight, and total fluid intake.  At one week, the sodium supplemented group was 
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in positive sodium balance compared to the nonsupplemented group and also 
had higher sodium balance at two weeks.  Weight loss was greater in the control 
group at one week, and at two weeks, most of the control group had not returned 
to their birth weights.   Even after sodium supplementation was discontinued, the 
experimental group’s growth velocity was greater.  Diuresis and water excretion 
were similar in both groups at week 1 and 2.  None of the supplemented babies 
had serum sodium levels greater than 145 mg/dL suggesting tolerance of 
increased sodium amounts (14). 
Al-Dahhan et al. (1984) conducted a randomized control trial that studied 
the clinical and biochemical effects of sodium supplementation given to twenty-
two otherwise healthy infants between 27-34 weeks’ gestational age from day of 
life 4 to 14 compared with a group of 24 unsupplemented babies (28).  Birth 
weight was regained more quickly in the supplemented infants, and they lost less 
weight postnatally, and their improved weight gain (g/kg/day) continued even 
after supplementation was discontinued.  Unsupplemented infants also 
experienced a significantly greater incidence of hyponatremia compared with the 
supplemented group.  No edema, hypernatremia, or evidence of circulatory 
overload was seen.  There was no significant difference in incidence of PDA, NEC, 
or IVH (28). 
Al-Dahhan et al. (2002) conducted a secondary analysis of previously 
sodium-supplemented infants (n=37) studying the effects of sodium 
supplementation on neurodevelopmental outcomes of 10-13 year olds.  Some of 
these adolescents had received sodium supplements on DOL 4-14 while 
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inpatients in a NICU (15).  They found that nine infants in the unsupplemented 
cohort had had plasma sodium levels of <130 mg/dL compared to four infants in 
the supplemented group.  The supplemented infants performed significantly 
better in balance and manual dexterity.  The supplemented group also had higher 
verbal intelligence quotients, and significantly different performance and full 
scale intelligence quotients.  Children in the unsupplemented group were also 
more than likely (p <0.07) than the unsupplemented group to have behavioral 
disturbances (15).  
CASE STUDIES 
 Several case reports identify a correlation between sodium depletion and 
poor growth.  Wassner and Kulin identified a boy status-post colon resection that 
occurred at one year of age (10).  One month after the surgery, he was admitted 
with an ileus and his serum sodium level was 119 mEq/L.  When seen again at 7 
years of age, his weight and height were below the 5th percentile on growth 
charts.  Sodium supplementation was begun and an increase in linear growth was 
seen.  When sodium intake was compared to growth per month, a significant 
correlation was seen (p<0.025) (10).   
 In a neonates with grade 3 Pierre Robin Sequence (a congenital condition 
of facial abnormalities, a retrospective chart review was conducted by Skillman et 
al. on infants born between 2000-2007 at a tertiary center for cleft palate care 
(32).  Twenty-nine infants who required nasogastric or nasopharyngeal 
intubation were included in the study.   After supplementation in 18 of the 21 
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infants who had low urinary sodium, weight gain improved significantly from 20 
to 24 g/day (p=<0.001) (32). 
 Sodium deficits can also be seen in infants with ileostomies.  Excessive 
sodium loss can occur with ileostomies because of poor or absent colon function 
(which helps retain fluid and sodium).  Bower et al. reviewed the records of 
eleven infants who were 25 to 38 weeks' gestation who experienced metabolic 
abnormalities caused by ileostomy fluid losses.  All these infants developed total 
body sodium depletion and metabolic acidosis from ileostomy bicarbonate loss.   
After sodium supplementation, however, these infants gained weight and a direct 
relationship was seen between ileostomy output and the sodium intake required 
for growth (which was calculated as an extra 0.13 mEq/kg/d of sodium for every 
ml/kg/d of ileostomy input) (16). 
 Sacher et al. saw similar findings in the retrospective follow up of 30 
neonates with ileostomies (17).  Because enteral products provide just 2-4 
mEq/kg of sodium, a sodium deficiency can amount to 4-6 mEq/kg a day with 
these patients.  After this amount was supplemented in the thirty infants, better 
growth was seen.  
 Infants with cystic fibrosis are at higher risk for sodium depletion which 
can lead to impaired growth.  In a study of ten cystic fibrosis patients, weights 
and plasma/urine sodium were obtained serially (33).   The amount of sodium 
supplementation was determined by fractional excretion of sodium and urinary 
sodium. Coates et al. found that no infant required more calories than estimated 
needs when their diet was sodium supplemented. 
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LATE HYPONATREMIA 
Late hyponatremia (low serum sodium levels after two weeks of age) has 
been observed in very low birth weight infants (birth weight of ≤1500 g) when 
they received 2-3.5 mEq/kg/day of sodium (34).  As these low birth weight 
infants transition from parenteral to enteral nutrition, sodium intake decreases 
while sodium requirements increase secondary to their growing more rapidly.  
This is further complicated by sodium losses during the initial weeks of life 
secondary to their kidneys’ ability to retain sodium (34).  
Roy el al. conducted a study of 46 very low birth weight infants between 
two to six weeks of age (35).  The nonsupplemented infants received less than 2 
mEq of sodium per kg/day.  The supplemented infants received ~3 mEq of 
sodium/kg/day.   Hyponatremia was seen on 54 of 159 occasions in the infants 
receiving sodium amounts of ≤2 mEq/kg/day.  
In a retrospective cohort study in 1996, Kloiber et al. examined data 
obtained from medical records of VLBW infants admitted to their NICU who 
experienced late hyponatremia (serum sodium <135 mg/dL between days of life 
14-56) (8).  There was an association between babies less than 1000 g and late 
hyponatremia, even though these infants received more sodium than the other 
infants.  This might have suggested a sodium deficiency and the need for 
increased sodium in these ELBW infants.  Because of this, Kloiber et al. estimated 
sodium requirements of ELBW infants at three to eight mEq/kg/day. 
 Infants less than 1500 grams are prone to development of hyponatremia 
which can lead to increased mortality and morbidity (36).  Ndwiga et al assigned 
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56 very low birth weight infants (1000-1500 g) to either an acutely ill group or 
clinically stable group.  The ill infants had persistently low serum sodium (mean 
of 120 mmol/L) during the first week while the clinically stable infants’ sodium 
levels increased from 127 to 133 mmol/L.   At day seven, there was a statistically 
significant difference in serum sodium levels (p=0.02).  
Unsupplemented breast milk may not be appropriate for low birth weight 
infants.  Ayisi et al. conducted a sodium supplementation study in 66 healthy 
infants who weighed between 1001-1500 grams at Kenyatta National Hospital 
Newborn Unit in Kenya (37).  Forty one infants were supplemented with sodium, 
while the twenty five in the control group were unsupplemented.   Serum sodium 
levels were measured in both groups during the 6-week study period.  Feedings 
were started at 60 ml/kg/day on day 1 and at day 7, 3 mEq/kg/day of sodium 
was supplemented for a total of 5.95 mEq/kg/day during the 5 consecutive 
weeks of supplementation, while sodium for the unsupplemented group was 2.75 
mEq/kg/day.  There was a statistically significant difference in the amount of 
sodium each group received (p < 0.01), although no significant difference was 
seen in mean serum sodium levels in both groups (140 ± 2 mEq/L vs. 139±+2 
mEq/L respectively).   Statistically significant differences were seen in weight, 
length, and head circumference in the group supplemented with sodium 
compared with the unsupplemented group (37). 
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MECHANISMS 
 The mechanism whereby sodium promotes cell growth is not completely 
understood, but it is hypothesized that the sodium/hydrogen antiporter system 
which controls the cell interior pH is a likely possibility (9). 
 The sodium/hydrogen (Na+-H+) exchanger has been documented in the 
plasma membrane of a wide variety of cell types and is a carrier-mediated Na+- 
H+ exchange (antiport, countertransport) system that exchanges sodium for 
hydrogen (11).  In the intact cell, the plasma membrane Na+-H+ exchanger 
controls the extrusion of protons and flux of Na+ into the cell.  This process does 
not need a chemical reaction (such as ATP hydrolysis) but energy is obtained 
from the Na+ gradient, which is maintained by the active extrusion of Na+ by the 
Na+,K+- ATPase system.  This plasma membrane sodium-hydrogen exchanger 
plays a physiological role in the regulation of intracellular pH and the control of 
cell growth and proliferation (11) and most likely does not function optimally 
with sodium deficiency. 
 All sodium transporting and regulating systems undergo maturation in the 
postnatal period.   Active sodium transport in all eukaryotic cells is provided by 
the Na+,K+-ATPase enzyme (25).  This transmembrane protein controls the 
electrochemical sodium and potassium gradient of the cell membrane.  Short 
term regulation of sodium balance is controlled by activity of sodium 
transporters.  Natriuresis is caused when these are down regulated by either 
atrial natriuretic peptide, dopamine, or diuretics.   Sodium retention occurs when 
these are upregulated by noradrenaline.   
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CHAPTER 3 
 
METHODOLOGY 
 
A retrospective chart review was conducted after approval by Women and 
Infants’ Hospital and the University of Rhode Island.  
Inclusion criteria for the study included birth weight less than or equal to 
1000 g and survival past 36 weeks gestational age.  Exclusion criteria included 
expiration prior to 36 weeks, admission into the NICU protein study, and transfer 
from another facility. 
Detailed patient information was extracted from patient medical records 
and parenteral nutrition software.  This information included birth weight, 
gestational age, length of stay, growth velocity, average protein and calorie intake 
per kilogram, and average sodium intake per kilogram received from all sources.   
These sources included enteral and parenteral nutrition, medications, and 
intravenous solutions.  The time points for data extraction included day of life 
one (1), four (4), seven (7), fourteen (14), twenty-one (21), twenty-eight (28), 
thirty-five (35), forty-two (42), fifty-six (56), seventy (70) and eighty-four (84). 
Presence of the following diagnoses was noted:  intraventricular 
hemorrhage (IVH), necrotizing enterocolitis (NEC), chronic lung disease (CLD), 
patent ductus arteriosus (PDA) and were extracted from diagnoses list on the 
electronic medical record. It has been shown that infants less than 1500 g with 
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one or more of these morbidities have a slower growth rate than the growth rate 
of infants who were not diagnosed with any of these morbidities (4). 
ELBW Database 
At WIH, data from infants less than or equal to 1000 grams are entered 
into the ELBW database located in Microsoft Access.  The purpose of a nutrition 
database for ELBW infants is to ensure that nutritional goals for this vulnerable 
group are being met.  ELBW infants have high nutritional needs and are at high 
risk of nutrition-related morbidities such as infection, necrotizing enterocolitis, 
chronic lung disease, and poor growth. The information recorded includes 
weight, IV fluids, parenteral nutrition, and enteral nutrition including additives.  
These data are collected on days of life 1, 4, 7, 14, 21, 28, 35, 42, 56, 70, and 84.  
Queries are used to determine the total calories, total protein, and total fluids per 
kilogram at these different time points, and these results were used for this 
study.   
Sodium from Parenteral Nutrition 
 Parenteral nutrition (PN) is provided to infants from the first or second 
day of life until transitioned to full enteral feeds.  Orders are written by the 
neonatal nutritionists utilizing Abacus Pharmaceutical Software (Version 2) after 
review by the interdisciplinary team and are based on laboratory data, diagnoses, 
and clinical status.  A new table was created in the ELBW database to enter 
sodium intake, and queries were used to calculate sodium in mEq/kg at all the 
time points.  The data abstraction tool that was used to collect this information 
from Abacus is found in Appendix B. 
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Sodium from Enteral Nutrition 
 Information about enteral nutrition was extracted from the queries 
already created in the ELBW database in Microsoft Access.  Different queries 
were used to calculate the amount of protein, calories, and sodium per kilogram 
that is contained in the appropriate formula.  Formula composition information 
was obtained from the manufacturers and this information was already in place 
in the database.  Nutrition composition of enteral feeds can be found in Appendix 
A. 
Sodium from Intravenous Solutions and Medications 
 At the chosen time points, sodium-containing IV solutions and all 
medications administered were documented using another data abstraction tool 
which can be found in Appendix B.  The amount in milliliters of each intravenous 
solution and medication was collected.  These values were then entered into the 
ELBW database in Microsoft Access and queries were used to determine sodium 
milliequivalents per kilogram.  
 Information about sodium content of medications was obtained from the 
manufacturers, from literature, and the pharmacy department at WIH.  Several 
medications are prepared in the pharmacy or at the bedside using normal saline, 
so even though the medication may not contain sodium, the administered dose 
will contain sodium because of its preparation.   A table depicting the 
medications, IV solutions and amounts of sodium per 100 ml can be found in 
Appendix C. 
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 Determining sodium levels from heparin was particularly difficult.  
Heparin that is added to intravenous solutions is a fraction of the entire bag.  
Together with Pharmacy, a calculation was used to represent heparin as a 
percentage of the total bag based on the amount of units/bag.  This can also be 
found on the Medication Sodium List found in Appendix C. 
Serum Sodium Values 
 Serum sodium values that were available at the time points were 
collected.   Because this was a retrospective study, not all infants had serum 
sodium levels at all the time points.  Also collected were the nadir and zenith 
serum sodium values as well as what day of life they were drawn. 
Calculating Growth Velocity 
 The growth velocity values used in the statistical analysis were calculated 
for each infant utilizing the two point method (38) which is shown below: 
 Growth Velocity = W2 - W1 ÷D ÷ W3, where 
  W2 = Weight at last week measured (g). 
  W1 = Birth weight (g) divided by  
  D = The number of weeks (converted to days) that data were 
collected. 
  W3 = W2 + W1/2 
Z-Scores 
At WIH, the Fenton Growth Chart is used as a tool to monitor growth while 
on the NICU, and this particular version is used for both males and females.  This 
growth chart highlights the 3rd, 10th, 50th, 90th, and 97th percentiles and is in place 
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in the electronic medical record.  Any weight not at the 50th percentile is 
considered a particular “distance” away from the median – or certain “z-score” 
away from 50th percentile.  For example, using percentiles, an infant could be 
plotted on the chart and described as weighing less than the 3rd percentile.  
When using z-scores, the infant’s weight is described more precisely as having a 
z-score of -2.7.   Using z scores is another tool to examine growth patterns.  Z-
scores less than -1.28 are considered growth restricted (3). 
Statistical Analyses 
 All of the data were consolidated into Microsoft Access 2010 (Seattle, WA), 
allowing extraction of the data from different sources for statistical analyses. 
Statistical analyses were done using SPSS Version 21 (IBM Corporation, Armonk, 
NY). 
The data were analyzed two ways.  First, all data points were used (days of 
life 1, 4, 7, 14, 21, 28, 35, 42, 56, 70 and 84) and these data underwent analysis 
using correlations, independent t-tests, and regression.   Because in 
uncomplicated cases, actual growth is not expected until after day of life 14 (2), 
the data were also analyzed from Week 2 through Week 12 with the same 
statistical tests.  
 Growth velocity, birth weight, nadir serum sodium value, zenith serum 
sodium value, average calories, average protein and average sodium intake were 
described using standard descriptive statistical methods (mean and standard 
deviation).  Normality for all variables was examined using the Shapiro Wilk test 
although because the sample size was 70 infants, normality was assumed using 
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the Central Limit Theorem which states that if sample size is greater than 30, the 
sample distribution can be safely assumed as normal (39). 
 Analyses of variance were performed on growth velocity vs. morbidities 
and average sodium intake for both sets of data (all time points and weeks 2-12).   
They were also performed on average inadvertent sodium intake and morbidities 
as well as average calorie intake and morbidities.  P<0.05 was considered 
significant. 
 Pearson correlations were run between average sodium, protein, and 
calorie intake, gestational age, birth weight and growth velocity at the specific 
time points as a means of exploring possible relationships.  This was used to 
provide a basis for variables that were entered into a multiple linear regression. 
 The initial analysis is a description of average sodium, protein, and calorie 
intake per kilogram from all sources and average weight.  Sodium intake 
averages were compared to recommendations set forth by the American 
Academy of Pediatrics. 
 
 24 
 
CHAPTER 4 
 
FINDINGS 
 
RESULTS 
Study Population 
One hundred eighty nine (189) extremely low birth weight infants were 
admitted to the Neonatal Intensive Care Unit at Women and Infants’ Hospital in 
Providence, Rhode Island from January 1, 2009 through June 30, 2011.  Of these, 
eighteen (18) were transferred from other hospitals, forty two (42) expired prior 
to week 12 of life, and fifty-eight (58) were enrolled in the NICU protein study, 
and one (1) was excluded because the electronic medical record was locked by 
the family and data could not be collected.  Seventy ELBW infants satisfied the 
inclusion criteria for the study.  All babies were hospitalized in the NICU through 
at least 35 days of life.  The sample remained essentially stable throughout the 
first six weeks of life, and three infants were discharged by day 42 (Figure 1).   
 25 
 
 
Figure 1.  Number of study infants at different time points. 
 
Characteristics of infants enrolled in the study are presented in Table 1 
including birth weight, gestational age, length of stay, and gender.  Fifteen infants 
(21%) were considered small for gestational age (SGA) weight -- plotted less than 
10% percentile on the Fenton Growth Chart or z score <-1.28 (indicating they 
were more than 1.28 standard deviations below the population mean).  Average 
calories, sodium, protein and growth velocity for both sets of time points (all time 
points and week 2-12 time points) can be found in Table 2.    
When comparing average sodium intake of the infants at all the time 
points, the most average sodium per kilogram was given at day 14 (4.52 mEq/kg) 
(Figure 2).  Average sodium, protein, and calories received by the study infants 
individually can be visualized in Figures 3, 4, and 5. 
Available labs for serum sodium (mmol/L) revealed that there were 
twenty five infants (36%) who experienced hyponatremia (serum sodium <130 
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mmol/L) and fourteen infants (20%) that experienced hypernatremia (serum 
sodium >150 mmol/L). 
Variable Mean ± SD 
or n (%) 
Birth Weight (g) 777±151 
Gestational Age (weeks) 26.4±2.12 
Length of Stay (days) 104±47.4 
SGA  15 (21%) 
Male  31 (44%) 
Female 39 (56%) 
Table 1.  Descriptive characteristics of infants included in study. 
 
Variable 
All Time Points 
(n=70) 
Time Points 
starting at Week 2 
(n=70) 
Mean Std 
Dev 
Mean Std Dev 
Avg Calories (cals/kg) 101.5 8.8 116.1 12.2 
Avg Sodium (mEq/kg) 2.97 0.69 2.1 0.59 
Avg Protein (g/kg) 3.3 0.25 1.8 0.06 
Growth Velocity (g/kg/d) 11.58 2.09 10.7 1.8 
Table 2.  Mean ± standard deviation of average calories, sodium, protein, and 
growth velocity for both time point sets. 
 
Figure 2.  Average sodium intake of all infants (mEq/kg/day) at different time 
points.  
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Figure 3.  Individual average sodium intake (mEq/kg/d) of study infants. 
 
 
Figure 4.  Individual average protein intake (g/kg/d) of study infants. 
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Figure 5.  Individual average calorie intake (kcal/kg/d) of study infants. 
 
Growth Velocity vs. Sodium Group 
 Growth velocities (g/kg/d) were compared between those infants 
receiving ≥3 mEq/kg of sodium and those receiving <3 mEq/kg of sodium using 
an analysis of variance with both sets of data (all time points and weeks 2-12).  In 
the all-time point set, 42 infants (60%) received an average of less than 3 mEq/kg 
of sodium and had a mean growth velocity of 12.01± 1.5 g/kg/day.  Twenty-eight 
infants (40%) received an average sodium intake of ≥3 g/kg/day and had a mean 
growth velocity of 10.93±2.64 g/kg/day.  There was a significant difference found 
between the two groups (p=0.034) (Figure 6).  When time points from only 
weeks 2-12 were included, 62 infants (89%) received an average sodium intake 
of <3 mEq/kg and only eight infants (11%) received an average sodium intake of 
≥3 g/kg/day.  No statistical significance was seen between groups (p=0.8376). 
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Figure 6.  Growth Velocity vs. sodium level [<3 mEq/kg (group 1) or ≥3  
mEq/kg (group 2)] all time points. 
 
 
Average Sodium Intake vs. Morbidities 
Thirty infants had no morbidities (43%) and 40 infants (57%) had one or 
more morbidity.   An ANOVA was performed between average sodium intake 
(mEq/kg/d) and infants with no morbidities and those with one or more 
morbidities in both time-point sets.  In the all-time-point set, there was a 
significant difference between the amount of sodium received and the number of 
morbidities [2.7 ±0.51 mEq/kg (none) vs. 3.16±0.75 mEq/kg (1-3 morbidities), 
p=0.0064] (Figure 7).  In the Weeks 2-12 data set, no statistical significance was 
seen between amount of sodium received no morbidities vs 1-3 morbidities 
(p=0.61). 
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Figure 7.  Total number of morbidities vs. average sodium (mEq/kg) all time 
points.  Group 0 = no morbidities; Group 1 = one or more morbidity. 
 
Growth Velocity vs. Number of Morbidities 
 An ANOVA was performed comparing growth velocity between those 
infants with no morbidities and those with one or more morbidities.  In the all-
time-point group, a significant difference was seen between the two groups 
(12.80±1.3 g/kg/d vs. 10.66±2.11 g/kg/d, p=0.001) (Figure 8).  In the 2-12 week 
time point group, no significant difference was seen (p= 0.0742). 
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Figure 8.  Total number of morbidities vs. growth velocity (all weeks). Group 0 = 
infants with no morbidities; Group 1 = infants with 1-3 morbidities. 
 
Average Calories Intake vs. Morbidities 
 
Average calorie intake (kcal/kg/d) was compared with two levels of 
morbidities (none or 1-3) for both time point data sets.  In the all-time point 
group, there was a significant difference between those infants without 
morbidities compared with those infants with morbidities (104±7.72 kcal/kg/d 
vs. 99.8±9.2 kcal/kg/d, p=0.036) (Figure 9).  In the time point data set from 2-12 
weeks, a significant difference was also seen between those infants without 
morbidities and those infants with one or more morbidity (119.44 kcal/kg/day 
113.6 kcal/kg/day, p=0.047) (Figure 10).  
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Figure 9  Average Calorie Intake vs. Morbidities for all time points.  Group 0 = no 
morbidities and group 1 = 1 – 3 morbidities. 
 
 
 
Figure 10 Average Calorie Intake vs. Morbidities for time points weeks 2-12.  
 Group 0 = no morbidities and group 1 = 1 – 3 morbidities. 
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Average Inadvertent Sodium Intake vs. Morbidities 
 Average inadvertent sodium intake was compared with the two morbidity 
sets (no morbidities vs. 1-3 morbidities).  The thirty infants without morbidities 
received 0.39±0.32 mEq/kg/d of sodium via medications and/or intravenous 
solutions.  The other 57% of the infants  (1-3 morbidities) received 0.83±0.58 
mEq/kg/day of sodium.  This revealed a significant difference (p=0.0005).  
(Figure 11).   In the Week 2-12 data set, the thirty infants without morbidities 
received 0.104±0.22 mEq/kg/d of sodium via medications and/or intravenous 
solutions.  The other 40 infants with 1-3 morbidities received 0.35±0415 
mEq/kg/day of sodium.  This also revealed a significant difference (p=0.044).    
 
Figure 11  Number of morbidities compared with average inadvertent sodium 
intake (mEq/kg/d).  Group 0 = no morbidities and group 1 = 1 – 3 morbidities. 
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Pearson Correlations 
Pearson correlations were conducted between variables growth velocity; 
average protein, average sodium, average calories, and birth weight) in the All 
Time Point data set.  Non-significant correlations were seen between growth 
velocity and average protein (r=-0.010).  Moderate correlations and statistical 
significance were seen between growth velocity and average sodium (r=-0.319; 
p=0.007); average calories (r=0.399,p=0.001); and birth weight (r=0.332, 
p=0.005).  In the Week 2-12 data set, no significant correlations were seen, thus, 
no regression analysis was done with this time-point grouping. 
Normality 
Normality for all variables was examined using the Shapiro Wilk test.   
Results of this testing is presented in Table 3.  While only growth velocity, 
protein, and calories were considered normally distributed in the all-time point 
group and only sodium and calories were considered normally distributed in the 
weeks 2-12 group, normality was assumed for all variables because of the large 
sample size citing the Central Limit Theorem (39). 
Variable All Time Points Weeks 2-12 
Shapiro 
Wilk 
P 
value 
Shapiro 
Wilk 
P 
value 
Growth Velocity 0.98 0.47 0.83 <0.001 
Protein 0.98 0.34 0.87 <0.001 
Sodium 0.92 0.004 0.97 0.28 
Calories 0.99 0.89 0.99 0.97 
Birth weight 0.95 0.01 0.95 0.01 
Gestational Age 0.92 0.001 0.92 0.001 
Length of Stay 0.91 0.001 0.91 0.001 
Table 3.  Results of the Shapiro Wilk analyses 
 35 
 
Regression 
 A multiple linear regression was used to test if average sodium intake 
significantly predicted growth velocity. The original model contained growth 
velocity (dependent variable), average sodium intake (mEq/kg/d), average 
calorie intake (kcal/kg/d), and average protein intake (g/kg/d).  The results of 
this regression indicated that the three predictors explained 22% of the variance 
[R2=0.22, F(3,66)=6.16, p=0.009].  Average protein showed no significance and 
was removed from the model (Table 4).   
 The final model included growth velocity (dependent variable), average 
sodium intake and average calories.  The results of this regression indicated that 
the two predictors explained 20% of the variance [R2=0.20, F(2,67)=8.71, 
p=0.004] (Table 5). 
 
Variable Label DF Parameter 
Estimate 
Standard 
Error 
t 
value 
Pr > t 
Intercept Intercept 1 8.08 4.07 1.99 0.05 
X1 Avg Protein 1 -0.96 0.94 -1.02 0.31 
X2 Avg Sodium 1 -0.702 0.345 -2.03 0.045 
X3 Avg Calories 1 0.086 0.027 3.12 0.003 
Table 4.  Parameter Estimates Original Model 
 
Variable Label DF Parameter 
Estimate 
Standard 
Error 
t 
value 
Pr > t 
Intercept Intercept 1 5.49 3.178 1.73 0.09 
X1 Avg Sodium  1 -0.69 0.345 -1.99 0.50 
X2 Avg Calories 1 0.0799 0.0268 2.98 0.004 
Table 5.  Parameter Estimates Final Model. 
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CHAPTER 5 
 
CONCLUSION 
 
 In this retrospective cohort study, it was shown that sodium intake of 
ELBW infants is suboptimal when compared to the AAP recommendations 
derived by Zeigler et al’s factorial method and the more recent recommendations 
of the AAP which is 3-5 mEq/kg/d) (2,18).  Comparisons of the time points 
showed the highest amount of sodium per kilogram to be given in the first two 
weeks of life, and the most was given on day of life 14 (4.52 mEq/kg).   This could 
be related to antibiotics given during that time -- antibiotics that contain large 
amounts of sodium in their preparation (i.e. ampicillin).  Other inadvertent 
amounts of sodium are administered from arterial lines (which are infused with 
normal saline), blood products, and resuscitation fluids.   
 Because more sodium, medications, and blood products are given during 
the first two weeks of life and because real growth occurs after week two (2), the 
data were also analyzed from week two through twelve.  When all time points 
were compared with the amount recommended by the AAP (3-5mEq/kg), only 
twenty-eight infants (40%) received the minimum amount.  When analyzed from 
weeks 2-12, only 11% of the infants received the minimum amount 
recommended. 
 Both sets of time point data were then split into two groups in order to 
compare growth velocity with amount of sodium received using 3 mEq/kg as a 
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cutoff.   When comparing data from all the time points, a faster growth rate was 
seen in the group given lower amounts of average sodium (12.01± 1.5 g/kg/day 
vs. 10.93±2.64 g/kg/day, p =0.034) and the same was true using weeks 2-12 
although not statistically different.  One could assume that this is related to these 
infants having one or more morbidities.  When growth rate of the infants who 
had no morbidities was compared to those infants with one or more morbidities, 
greater growth rates were seen in the group with no morbidities (12.80±1.3 
g/kg/day vs. 10.66±2.11, p=0.001)  
Surprisingly, average protein intake did not appear to be correlated to 
growth velocity in this sample although other studies have supported such a 
relationship (4,8).  It may have been because many of the infants received close 
to adequate protein amounts (~3 g/kg/d).   In the present study, growth velocity 
seemed to be better explained by caloric intake rather than sodium or protein 
intake.  It is worth noting that growth velocity averaged only 11.58±2.09 
g/kg/day (all time points) and 10.7±1/8 (weeks 2-12), which is substantially 
below the 15 g/kg/day recommended by AAP (2).  Furthermore the factorial 
method of estimating needs assumes 130 calories, and the infants in this study 
averaged only 101.5±8.8 kcal/kg (all time points) and 116.10±12.2 kcals/kg 
(weeks 2-12).  It is also noteworthy that when comparing z scores from birth to 
discharge, only 7 of the infants (10%) increased their z score while hospitalized.  
This further strengthens the thought that there is still additional work to be done 
to improve growth outcomes.  
 When exploring gender and growth velocity, there was a statistical 
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difference seen between gender and growth velocity in the all-time point 
grouping (p=0.035).  Because the NICU at WIH utilizes just one growth chart 
(Fenton) (40), a decision was made not to control for this in the analyses. 
In the final regression model, average sodium was not a predictor of 
growth velocity, and it appeared that average calorie amount may have been 
more important in predicting growth velocity.   
LIMITATIONS AND STRENGTHS 
Because blood draws are kept to a clinically-necessary minimum in the 
NICU to reduce the need for blood transfusions, serum sodium values were not 
available on all babies at all-time points in the way needed for a research study 
about sodium intake.  This also assumes that serum sodium levels are the best 
way to assess sodium balance in preterm infants.   Flushes received at the 
bedside were not counted in this study as they are not documented in the 
electronic medical record yet registered nurses do this routinely.  The strengths 
of this study included the sample size and consideration of multiple factors that 
may impact growth velocity in ELBW infants.  Examining sodium from all sources 
across the entire length of stay for these infants also provided valuable clinical 
information.  
FUTURE RESEARCH 
 It would be useful to approach sodium administration in a randomized 
controlled study using the approaches established previously such as delaying 
the administration of sodium until diuresis occurs and serum sodium is less than 
130-135 mmol/L in order to prevent fluid overload.   After this diuresis, two 
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study groups could be formed, controlling for morbidities and level of sodium 
administration.   Methods for documenting inadvertent sodium administration 
should be implemented in order to quantify total sodium throughout the stay 
ruling out extra sodium as a cause for morbidities experienced by preterm 
infants. 
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Appendix A 
Nutrition Composition of Enteral Feeds 
 
 
Protein  
(g) 
Iron  
(mg) 
Calcium 
(mg) 
Vit D 
(IU)  
Zinc 
(mg) 
Na 
(mEq) 
K 
(mEq) 
20 Human Milk20 (HM), Mature 1.54 0.04 41 3 0.18 1.1 2 
22 
HM20+Similac HMF2 (50mL:1 
pkt) 
2.1 0.3 115 83 0.8 1.5 2.9 
24 HM20+SHMF4 (25mL:1 pkt) 2.5 0.5 177 149 1.4 1.7 3.6 
27 HM20+SHMF4+Neo3/EnfaCare3 2.3 0.6 169/171 140 1.4/1.3 1.7 3.6/3.5 
30 HM20+SHMF4+Neo6/Enfa6 2.5 0.7 163/166 133/134 1.3 1.7 3.6/3.5 
24 HM20+Neo4/EnfaCare4 1.7 0.3 51/54 14 0.4/0.3 1.2 2.3/2.1 
27 HM20+Neo7/EnfaCare7 1.8 0.5 57/61 20 0.4 1.2/1.3 2.4/2.2 
30 HM20+Neo10/EnfaCare10 1.9 0.6 62/67 25 0.5 1.2/1.3 2.5/2.2 
20 Enfamil Premature Lipil (PE) 3 1.8 165 240 1.5 2.5  2.5 
24 PE High Protein24 3.5 1.8 165 240 1.5 2.5 2.5 
27 PE High Protein24+SC30 (1:1) 3.25 1.8 173 195 1.5 2.2 2.9 
20, 
30 
Similac Spec Care Adv (SC) 3 1.8 180 150 1.5 1.9 3.3 
24 SC High Protein24 3.3 1.8 180 150 1.5 1.9 3.3 
27 SC High Protein24+SC30 (1:1) 3.15 1.8 180 150 1.5 1.9 3.3 
≤ 
30 
EnfaCare 2.8 1.8 120 70 1.3 1.5 2.7 
≤ 
30 
NeoSure 2.8 1.8 105 70 1.2 1.4 3.6 
≤ 
30 
Enfamil 2.1 1.8 78 60 1 1.2 2.8 
≤ 
30 
GoodStart  2.2 1.5 67 60 0.8 1.2 2.8 
≤ 
30 
Similac 2.1 1.8 78 60 0.8 1 2.7 
≤ 
24 
Alimentum 2.8 1.8 105 45 0.8 1.9 3 
≤ 
24 
Nutramigen 2.8 1.8 94 50 1 2 2.8 
≤ 
24 
Pregestimil (50% MCT oil) 2.8 1.8 94 50 1 2  2.8 
≤ 
24 
Elecare for Infants 3.1 1.5 116 60 0.8 2 3.9 
≤ 
24 
Neocate Infant (33% MCT oil) 3.1 1.9 124 60 1.7 1.6 4 
≤ 
30 
Nutramigen AA 2.8 1.8 94 50 1 2 2.8 
≤ 
30 
EnfaPort (84% MCT oil) 3.5 1.8 94 50 1 1.3 2.9 
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Appendix B 
Data Abstraction Tools 
 
Sodium from TPN 
 ID Number: 
Day of Life Date Amount (mEq) Serum Sodium 
0    
1    
Yesterday    
4    
Yesterday    
7    
Yesterday    
14    
Yesterday    
21    
Yesterday    
28    
Yesterday    
35    
Yesterday    
42    
Yesterday    
56    
Yesterday    
70    
Yesterday    
84    
Yesterday    
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Sodium from Medications and Intravenous Solutions 
 
Day 
of 
Life 
Date Medication Amt 
Rec 
Medication Amt 
Rec 
Medication 
0       
1       
4       
7       
14       
21       
28       
35       
42       
56       
70       
84       
Day 
of 
Life 
Date Medication Amt 
Rec 
Medication Amt 
Rec 
Medication 
0       
1       
4       
7       
14       
21       
28       
35       
42       
56       
70       
84       
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Appendix C 
Sodium Amounts in Medications (41) 
 
Medications that 
contain zero 
sodium Medication  Amount Medication  Amount 
Amlodipine Omeprazole 200 Furosemide 13.86 
Caffeine Citrate 3% NS 51.3 LR, D5 13 
Cefepime Na Bicarbonate 50 LR 13 
Chlorothiazide Aquadek 43 Oxacillin 12.5 
Clindamycin Packed RBC 31.3 Indocin 12.32 
Dexamethasone Platelets 30.5 Midazolam 10 
Diuril Ampicillin 29 cefotaxime 10 
 Dobutamine Ceftazidime 21.85 
10 mEq 
Na/100 10 
Dopamine 
Fresh Frozen 
Plasma 17.2 8 mEq Na/100 8 
Ergocalciferol Meropenum 15.455 0.45% NS 7.7 
Fat Emulsion 
Dopamine w/ 
NaCL 0.9 15.4 
4.6 mEq 
Na/100 4.6 
Fentanyl 200 mcg 0.9% NS 15.4 23.4% NaCl 4.003 
fentanyl 50 mcg Plasmanate 15.4 4 mEq Na/100 4 
Fentanyl 500 mcg 
Saline Flush 
(0.9%NS) 15.4 Amphoterin B 3.7 
Fentanyl bolus Cosyntropin 15.34 0.225% NS 3.4 
FeSO4 
Fentanyl w NaCL 
0.9% 15.04 
Vecuronium 
10 mg vial 3 
Fluconazole Metaclopramide 15 2 mEq Na/100 2 
Ibuprofen Hydralazine 14.63 Tylenol 1.74 
Inositol Albumin, 25% 14.5 hydrocortisone 0.3 
Intralipid Phenobarbitol 14.168 Heparin 100 u 0.154 
Morphine Metronidazole 14 Gentamicin 0.054 
Polyvisol w/ Iron Lasix 13.86 Heparin 25 u 0.0385 
Potassium 
Chloride 
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